These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


138 related items for PubMed ID: 36858039

  • 1. Ceftaroline and Avibactam Removal by Continuous Renal Replacement Therapies: An in vitro Study.
    Alarcia-Lacalle A, Barrasa H, Maynar J, Canut-Blasco A, Solinís MÁ, Isla A, Rodríguez-Gascón A.
    Blood Purif; 2023; 52(5):464-473. PubMed ID: 36858039
    [Abstract] [Full Text] [Related]

  • 2. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
    Isla A, Gascón AR, Maynar J, Arzuaga A, Toral D, Pedraz JL.
    Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Optimizing ceftaroline dosing in critically ill patients undergoing continuous renal replacement therapy.
    Kalaria S, Williford S, Guo D, Shu Y, Medlin C, Li M, Yeung SYA, Ali F, Jean W, Gopalakrishnan M, Heavner M.
    Pharmacotherapy; 2021 Feb; 41(2):205-211. PubMed ID: 33438291
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cost analysis of two modalities of continuous renal replacement therapy.
    Duriseti P, Idrees N, Aldairem A, Jaber BL, Balakrishnan VS.
    Hemodial Int; 2021 Apr; 25(2):173-179. PubMed ID: 33103356
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of levofloxacin during continuous venovenous hemodiafiltration and continuous venovenous hemofiltration in critically ill patients.
    Guenter SG, Iven H, Boos C, Bruch HP, Muhl E.
    Pharmacotherapy; 2002 Feb; 22(2):175-83. PubMed ID: 11837556
    [Abstract] [Full Text] [Related]

  • 12. Levetiracetam pharmacokinetics in critically ill patients undergoing renal replacement therapy.
    Chappell K, Kimmons LA, Haller JT, Canada RB, He H, Hudson JQ.
    J Crit Care; 2021 Feb; 61():216-220. PubMed ID: 33217623
    [Abstract] [Full Text] [Related]

  • 13. Tigecycline in critically ill patients on continuous renal replacement therapy: a population pharmacokinetic study.
    Broeker A, Wicha SG, Dorn C, Kratzer A, Schleibinger M, Kees F, Heininger A, Kees MG, Häberle H.
    Crit Care; 2018 Dec 17; 22(1):341. PubMed ID: 30558639
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Human Proenkephalin A 119-159 (penKid) in Extracorporeal Therapies: Ex vivo Sieving Coefficient, Diffusive Clearance, and Hemoadsorption Kinetics.
    Lorenzin A, de Cal M, Perin N, Morisi N, Brendolan A, Lentini P, Zanella M, Ronco C.
    Blood Purif; 2024 Dec 17; 53(10):773-780. PubMed ID: 39068927
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Low Blood Flow Continuous Veno-Venous Haemodialysis Compared with Higher Blood Flow Continuous Veno-Venous Haemodiafiltration: Effect on Alarm Rates, Filter Life, and Azotaemic Control.
    Sansom B, Sriram S, Presneill J, Bellomo R.
    Blood Purif; 2022 Dec 17; 51(2):130-137. PubMed ID: 34010832
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [The effects of dialysate and ultrafiltration flow rate on solute clearance during continuous renal replacement therapy].
    Gong D, Ji D, Xie H, Xu B, Liu Y, Li L.
    Zhonghua Nei Ke Za Zhi; 2001 Mar 17; 40(3):183-6. PubMed ID: 11798577
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.